Skip to main content

Table 4 Comparison of treatment results between the two groups

From: A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas

  SEQ CON p
Overall survival (5 ys.) 14.7 % 23.7 % 0.11
Median overall survival 14.6 months 20.1 months  
Disease-free survival (5 ys.) 19.8 % 31.4 % 0.08
Progression free survival (5 ys.) years) 17.6 % 41.0% 0.03
Median time to (local) progression 10.7 months 15.0 months  
  1. 1) WHO 2) compared with response in the SEQ-group after chemotherapy and radiotherapy